Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Royalty Pharma Plc Cl A (RPRX)

Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,620,641
  • Shares Outstanding, K 597,435
  • Annual Sales, $ 2,355 M
  • Annual Income, $ 1,135 M
  • 60-Month Beta 0.45
  • Price/Sales 7.14
  • Price/Cash Flow 6.11
  • Price/Book 1.65
Trade RPRX with:

Options Overview Details

View History
  • Implied Volatility 37.39% ( +5.84%)
  • Historical Volatility 19.11%
  • IV Percentile 90%
  • IV Rank 71.21%
  • IV High 46.36% on 02/13/24
  • IV Low 15.19% on 05/12/23
  • Put/Call Vol Ratio 0.03
  • Today's Volume 218
  • Volume Avg (30-Day) 411
  • Put/Call OI Ratio 0.96
  • Today's Open Interest 9,492
  • Open Int (30-Day) 13,993

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 0.96
  • Number of Estimates 3
  • High Estimate 1.01
  • Low Estimate 0.91
  • Prior Year 1.60
  • Growth Rate Est. (year over year) -40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.21 +0.40%
on 04/23/24
30.80 -11.30%
on 03/28/24
-2.95 (-9.75%)
since 03/22/24
3-Month
27.21 +0.40%
on 04/23/24
31.66 -13.69%
on 02/27/24
-2.06 (-7.01%)
since 01/23/24
52-Week
25.92 +5.40%
on 09/21/23
36.19 -24.51%
on 04/24/23
-8.78 (-24.32%)
since 04/21/23

Most Recent Stories

More News
Wall Street Thinks These 3 Stocks Are Hidden Gems That Could Soar 43% to 59% Over the Next 12 Months

Analysts are quite bullish about these beaten-down stocks.

SLB : 49.61 (+0.20%)
BABA : 72.35 (+2.36%)
RPRX : 27.65 (-0.61%)
Why PTC Therapeutics Soared 15% Higher Today

The company scored a $1 billion upfront payment for expanding a commercial partnership.

PTCT : 25.97 (+0.15%)
RPRX : 27.65 (-0.61%)
2 Dividend Stocks Wall Street Thinks Can Rise by 50%

These stocks could give investors the best of both worlds: dividend income and the potential to earn a great profit.

RPRX : 27.65 (-0.61%)
JD : 27.54 (+2.04%)
Royalty Pharma (RPRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Royalty Pharma (RPRX) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates...

RPRX : 27.65 (-0.61%)
Royalty Pharma (RPRX) Q1 Earnings and Revenues Top Estimates

Royalty Pharma (RPRX) delivered earnings and revenue surprises of 21.21% and 23.65%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

RPRX : 27.65 (-0.61%)
MDWT : 26.99 (unch)
Should You Buy Royalty Pharma (RPRX) Ahead of Earnings?

Royalty Pharma (RPRX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

RPRX : 27.65 (-0.61%)
Owl Rock Capital Corporation (ORCC) Reports Next Week: Wall Street Expects Earnings Growth

Owl Rock Capital Corporation (ORCC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ORCC : 13.48 (-0.15%)
RPRX : 27.65 (-0.61%)
Royalty Pharma (RPRX) Reports Next Week: Wall Street Expects Earnings Growth

Royalty Pharma (RPRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

RPRX : 27.65 (-0.61%)
NEWT : 11.01 (-0.45%)
MVB Financial (MVBF) Q1 Earnings and Revenues Miss Estimates

MVB Financial (MVBF) delivered earnings and revenue surprises of -65.52% and 12.83%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

MVBF : 20.02 (-0.30%)
RPRX : 27.65 (-0.61%)
Why Is PRA Group (PRAA) Down 10.4% Since Last Earnings Report?

PRA Group (PRAA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

PRAA : 24.88 (+5.11%)
RPRX : 27.65 (-0.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Royalty Pharma plc is a funder of biopharmaceutical industry. The compnay's portfolio includes royalties on commercial products, including AbbVie and J&J's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Gilead's HIV franchise, Merck's Januvia, Novartis' Promacta and Vertex's Kalydeco, Symdeko...

See More

Key Turning Points

3rd Resistance Point 28.97
2nd Resistance Point 28.69
1st Resistance Point 28.25
Last Price 27.65
1st Support Level 27.53
2nd Support Level 27.25
3rd Support Level 26.81

See More

52-Week High 36.19
Fibonacci 61.8% 32.27
Fibonacci 50% 31.06
Fibonacci 38.2% 29.84
Last Price 27.65
52-Week Low 25.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar